This announcement is a separate document:
科濟藥業-B：內幕信息公告 - 因CMC相關問題在美國暫停臨床試驗
CARSGEN-B: INSIDE INFORMATION ANNOUNCEMENT - CLINICAL HOLD IN THE U.S. DUE TO CMC RELATED QUESTIONS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.